• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术后肠系膜上动脉壁切应力:黏液性腹膜假黏液瘤不完全细胞减灭术后残留疾病患者长期结局的生物标志物。

Post-operative wall shear stress in the superior mesenteric artery: Biomarker of long term outcome in patients with residual disease after incomplete cytoreductive surgery for pseudomyxoma peritonei.

机构信息

Sorbonne Paris Cité, Université Paris7 Denis Diderot, Paris, France; CART, INSERM UMR965, Hôpital Lariboisière, F-75010, Paris, France.

Sorbonne Paris Cité, Université Paris7 Denis Diderot, Paris, France; CART, INSERM UMR965, Hôpital Lariboisière, F-75010, Paris, France; AP-HP, Hôpital Lariboisière, Physiologie Clinique - Explorations Fonctionnelles, F-75010, Paris, France.

出版信息

Eur J Surg Oncol. 2019 Sep;45(9):1727-1733. doi: 10.1016/j.ejso.2019.03.001. Epub 2019 Mar 6.

DOI:10.1016/j.ejso.2019.03.001
PMID:30871885
Abstract

BACKGROUND

After incomplete cytoreductive surgery (CRS), the assessment of pseudomyxoma peritonei (PMP) progression remains challenging. The objective was to assess the efficacy of wall shear stress (WSS) measured in superior mesenteric artery (SMA) to predict PMP progression in the postoperative setting to propose additional treatments.

METHODS

In a prospective study, 52 patients with PMP had Doppler-ultrasound examination of the SMA with WSS calculation within one year after CRS with a mean follow-up of 43.3 ± 18.3 months. Patients were categorized according to the completeness of CRS and clinical outcome: Group-1 (n = 19): complete CRS and no recurrence, group-2 (n = 20): incomplete CRS with slowly progressive disease (alive at 2 years without severe clinical symptoms), group-3 (n = 13): incomplete CRS and severe clinical symptoms or dead within two years. Results of WSS were compared between groups and to 24 healthy subjects.

RESULTS

WSS measured in the SMA was superior in Group-3 (19.6 ± 8.2 dynes/cm) than in Group-2 (9.2 ± 1.8 dynes/cm, p = 1.10), Group-1 (10.4 ± 2.8 dynes/cm, p = 8.10), and healthy patients (8.7 ± 2.8 dynes/cm, p = 9.10). One year after surgery, among patients with incomplete CRS a cut-off value of 12.1dynes/cm allowed distinguishing patients without from those with severe disease progression with a sensitivity of 100% and a specificity of 100% (p < 1.10) AUC = 1.000 [95%CI: 0.897-1.000].

CONCLUSION

Post-operative assessment of the WSS in the SMA in patients with incomplete CRS for PMP should be considered as biomarker of tumor progression in the postoperative setting. Therefore, WSS could be useful to target patients needing adjuvant systemic chemotherapy one year after CRS.

摘要

背景

在不完全细胞减灭术后(CRS),评估假性黏液瘤腹膜(PMP)进展仍然具有挑战性。本研究的目的是评估肠系膜上动脉(SMA)壁切应力(WSS)测量在预测术后 PMP 进展方面的有效性,以提出额外的治疗方法。

方法

在一项前瞻性研究中,52 例 PMP 患者在 CRS 后一年内接受了 SMA 的多普勒超声检查和 WSS 计算,平均随访时间为 43.3±18.3 个月。根据 CRS 的完整性和临床结果将患者分为三组:组 1(n=19):完全 CRS 且无复发;组 2(n=20):不完全 CRS 且疾病进展缓慢(两年内无严重临床症状且存活);组 3(n=13):不完全 CRS 且两年内出现严重临床症状或死亡。比较了各组之间以及与 24 名健康受试者之间的 WSS 结果。

结果

组 3(19.6±8.2 dynes/cm)的 SMA 中测量的 WSS 明显高于组 2(9.2±1.8 dynes/cm,p=1.10)、组 1(10.4±2.8 dynes/cm,p=8.10)和健康患者(8.7±2.8 dynes/cm,p=9.10)。在不完全 CRS 的患者中,手术后一年,12.1 dynes/cm 的截断值可区分无严重疾病进展的患者和有严重疾病进展的患者,其敏感性为 100%,特异性为 100%(p<1.10),AUC=1.000 [95%CI:0.897-1.000]。

结论

对于接受不完全 CRS 治疗的 PMP 患者,术后 SMA 中 WSS 的评估应被视为术后肿瘤进展的生物标志物。因此,WSS 可用于在 CRS 后一年靶向需要辅助全身化疗的患者。

相似文献

1
Post-operative wall shear stress in the superior mesenteric artery: Biomarker of long term outcome in patients with residual disease after incomplete cytoreductive surgery for pseudomyxoma peritonei.术后肠系膜上动脉壁切应力:黏液性腹膜假黏液瘤不完全细胞减灭术后残留疾病患者长期结局的生物标志物。
Eur J Surg Oncol. 2019 Sep;45(9):1727-1733. doi: 10.1016/j.ejso.2019.03.001. Epub 2019 Mar 6.
2
Prediction of clinical outcome using blood flow volume in the superior mesenteric artery in patients with pseudomyxoma peritonei treated by cytoreductive surgery.采用细胞减灭术治疗的腹膜假黏液瘤患者中,利用肠系膜上动脉血流量预测临床结局
Eur J Surg Oncol. 2017 Oct;43(10):1932-1938. doi: 10.1016/j.ejso.2017.05.015. Epub 2017 May 25.
3
Blood Flow and Shear Stress Allow Monitoring of Progression and Prognosis of Tumor Diseases.血流和剪切应力有助于监测肿瘤疾病的进展和预后。
Front Physiol. 2021 Aug 3;12:693052. doi: 10.3389/fphys.2021.693052. eCollection 2021.
4
Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.细胞减灭术联合腹腔热灌注化疗治疗腹膜假黏液瘤患者中循环肿瘤标志物的预后价值
Ann Surg Oncol. 2007 Aug;14(8):2300-8. doi: 10.1245/s10434-007-9393-9. Epub 2007 May 18.
5
Should total gastrectomy and total colectomy be considered for selected patients with severe tumor burden of pseudomyxoma peritonei in cytoreductive surgery?在减瘤手术中,对于某些腹膜假黏液瘤肿瘤负荷严重的患者,是否应考虑行全胃切除术和全结肠切除术?
Eur J Surg Oncol. 2016 Jul;42(7):1018-23. doi: 10.1016/j.ejso.2016.04.059. Epub 2016 May 19.
6
[A single-center clinical analysis of 65 cases of pseudomyxoma peritonei from appendiceal origin in the early stage].[65例阑尾源性早期腹膜假黏液瘤的单中心临床分析]
Zhonghua Zhong Liu Za Zhi. 2019 Sep 23;41(9):698-702. doi: 10.3760/cma.j.issn.0253-3766.2019.09.010.
7
Pseudomyxoma Peritonei of Extra-Appendiceal Origin: A Comparative Study.阑尾外源性腹膜假黏液瘤:一项对比研究。
Ann Surg Oncol. 2016 Dec;23(13):4222-4230. doi: 10.1245/s10434-016-5350-9. Epub 2016 Jun 28.
8
Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei.腹膜假黏液瘤减瘤手术及腹腔内化疗中的药物敏感性测试
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S810-6. doi: 10.1245/s10434-015-4675-0. Epub 2015 Jul 21.
9
The pre-operative neutrophil-lymphocyte ratio predicts overall and disease-free survival following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with pseudomxyoma peritonei of appendiceal origin.术前中性粒细胞与淋巴细胞比值可预测阑尾来源腹膜假黏液瘤患者行细胞减灭术(CRS)和腹腔热灌注化疗(HIPEC)后的总生存和无病生存。
Int J Hyperthermia. 2018 Aug;34(5):559-563. doi: 10.1080/02656736.2017.1384073. Epub 2017 Oct 24.
10
Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.阑尾来源的假性黏液瘤腹膜病患行细胞减灭术和腹腔热灌注化疗策略治疗的早、长期预后数据。
J Clin Oncol. 2012 Jul 10;30(20):2449-56. doi: 10.1200/JCO.2011.39.7166. Epub 2012 May 21.

引用本文的文献

1
Combined ultrasonography and CT for prognosis and predicting clinical outcomes of patients with pseudomyxoma peritonei.联合超声和 CT 对腹膜假性黏液瘤患者的预后和临床结局预测。
Eur Radiol. 2023 Apr;33(4):2800-2808. doi: 10.1007/s00330-022-09242-z. Epub 2022 Nov 23.
2
Blood Flow and Shear Stress Allow Monitoring of Progression and Prognosis of Tumor Diseases.血流和剪切应力有助于监测肿瘤疾病的进展和预后。
Front Physiol. 2021 Aug 3;12:693052. doi: 10.3389/fphys.2021.693052. eCollection 2021.